Practitioner Type:
Psychiatrist
Areas of Specialty:
Codependency , Coping, Family Therapy , Grief , Mindfulness Training, Psychedelic-Assisted Therapy, Psychiatry, Psychotherapy, Relationship Therapy, Trauma Focused
Teletherapy Offered:
Yes
Conditions Treated:
ADHD, Anxiety, Behavioral Issues, Bipolar Spectrum, Depression, Mood Disorders, Obsessive Compulsive (OCD), PTSD, Self Esteem
Psychedelic Assisted Services:
Esketamine, Ketamine
Substance Assistance Services:
Esketamine Treatment, Ketamine Assisted-Psychotherapy
Population Served:
Adolescents, Adults, Children, Families
Languages Spoken:
English
Insurance Plans:
Aetna, Anthem, Beacon, BlueCross And BlueShield, Cigna, Kaiser, Magellan, MHN, Optum, Other, TRICARE, TriWest, UnitedHealthcare UHC
About
We’re a team of clinicians and staff who have dedicated our lives to research, education, and treating those with mental health conditions. We’re especially passionate about helping those with Treatment-Resistant Depression and providing the most advanced therapies available, including Transcranial Magnetic Stimulation (TMS) and esketamine nasal spray, both FDA-approved for advanced depression.
Mental health conditions can be profoundly painful and isolating, making it difficult to seek help. Our team provides a unique, patient-centered experience to help you find the appropriate treatment and relief from your symptoms. We’re grateful to be practicing psychiatry during this era in which there are so many new treatment possibilities and new hope for those with mental health conditions. Learn more below about the many ways our team strives to provide our patients with the best possible care.
Redefining Outpatient Psychiatry
Since its founding in 2007, Mindful Health Solutions has been an innovation leader in psychiatry with a focus on pioneering cutting-edge therapeutics for treatment-resistant depression and other psychiatric Illness. We founded one of the first TMS-focused clinics in the US and have deep expertise in the field of non-invasive brain stimulation. We then went on to establish one of the first clinics to provide Esketamine (Spravato) therapy at scale, and recently incorporated Intravenous Ketamine into our depression treatment pathway.
Patients at Mindful Health Solutions have access to true thought leaders in the field focused on bringing academic rigor and years of experience with novel therapeutics to an integrated treatment strategy. Currently we are leaning into the promise of psychedelic therapies for depression and PTSD as well as leveraging our extensive clinical outcomes repository to develop predictive algorithms that will help guide our clinicians in selecting the best treatment modality for their patients.
We have grown to 24 outpatient clinics located in California, Georgia, Texas, and Washington and continue to expand our innovative, precision-medicine platform into new markets.
Commitment To Innovation
Our clinicians enjoy the company of talented, motivated, and highly experienced colleagues with a passion for lifelong learning. Together, we cultivate a culture of creativity and collaboration that encourages thinking outside the box. Our practitioners actively research new therapies, new paths for patient education, and new ways to make our practice and services more effective. We are also currently exploring new applications for Transcranial Magnetic Stimulation (TMS). We are also developing telepsychiatry and patient engagement apps to extend and enhance our patients’ experience.
Interventional Psychiatry Expertise
Our experienced clinical leadership team has been applying innovative treatment protocols through TMS, Esketamine, and IV Ketamine for years supported by positive outcome data. Mindful Health Solutions has one of the largest TMS and Esketamine patient outcome repositories in the world, consisting of over 1 million data points from 50,000+ patients with more than 300,000 patient visits to track our patients’ progress in real time and develop algorithms that help predict the probability of successful interventional treatment outcomes.
